Unusual Options Activity: UBER, MMM and Others Attract Market Bets, UBER V/OI Ratio Reaches 615.4
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Sonova Holding AG (Six Swiss: CH:SOON) and Corbus Pharmaceuticals (CRBP)
Biogen (BIIB.US) and UCB's lupus new drug, daclizumab, late-stage trial successful, reversing early failures.
Baiqian and its Belgian partner UCB announced on Tuesday that their experimental lupus treatment drug, Dapirolizumab pegol, met the primary endpoint in late-stage trials.
GSK's Menveo Meningococcal Vaccine in New Single-vial, Fully Liquid Presentation Receives Positive European CHMP Opinion
Sharp Sword! The FTC sues three major pharmaceutical 'middlemen', vowing to correct the distorted chain of interests.
①The USA FTC announced on its official website that it has filed a lawsuit against three major pharmaceutical benefit managers and their affiliated organizations, accusing them of engaging in anti-competitive and unfair rebate practices; ② The FTC also "explicitly stated" in the declaration that it is deeply concerned about the roles played by Eli Lilly, Novo-Nordisk, and Sanofi, insulin pharmaceutical companies, and may suggest in future enforcement actions to prosecute these pharmaceutical manufacturers.
